Therefore, the modulation of the TGF-β1/Smad signaling pathway is important for improving lung fibrosis in ARDS as it is involved in inflammation, mesenchymal transition, and ECM deposition [26,27]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.